Position in LLY
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$18,082,608
+$4,075,431 QoQ
Shares Held
15,076
-1.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.98%
of 13F equity value
Holder Rank
#933
of 4,604 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TWIN CAPITAL MANAGEMENT INC holds $51,361,248 across 9 Drug Manufacturers - General names. LLY ranks #1 (35.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
15,076 | $18,082,608 | |
| 2 | JNJ |
Johnson & Johnson
|
47,173 | $11,980,526 | |
| 3 | AMGN |
Amgen Inc
|
15,782 | $5,714,977 | |
| 4 | MRK |
Merck & Co., Inc.
|
40,649 | $5,223,396 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
80,607 | $4,644,575 | |
| 6 | ABBV |
AbbVie Inc.
|
11,313 | $2,846,803 | |
| 7 | PFE |
Pfizer Inc
|
58,541 | $1,409,667 | |
| 8 | BIIB |
Biogen Inc.
|
4,465 | $964,707 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,082,608 | 15,076 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $14,007,177 | 15,229 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $16,821,967 | 15,653 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $12,025,643 | 15,761 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $15,104,173 | 19,376 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $14,822,606 | 17,947 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $14,135,320 | 18,310 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $15,992,102 | 18,051 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $16,043,333 | 17,720 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $11,639,837 | 14,962 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $8,356,158 | 14,335 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $10,250,588 | 19,084 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $8,142,899 | 17,363 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $5,156,451 | 15,015 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $6,814,501 | 18,627 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $6,118,428 | 18,922 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $5,817,658 | 17,943 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $4,907,522 | 17,137 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $4,849,594 | 17,557 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $3,494,631 | 15,125 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $7,086,889 | 30,877 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $7,396,577 | 39,592 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $7,842,955 | 46,452 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $7,217,159 | 48,758 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $7,748,639 | 47,196 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $6,833,347 | 49,260 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||